Effect of Preexisting Neutralizing Antibodies on the Anti-tumor Immune Response Induced by Chimeric Human Papillomavirus Virus-like Particle Vaccines
- 1 November 2001
- Vol. 290 (2) , 350-360
- https://doi.org/10.1006/viro.2001.1179
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Physical interaction of human papillomavirus virus-like particles with immune cellsInternational Immunology, 2001
- Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies of HPV-16 E7-expressing DNA vaccinesVaccine, 2000
- Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunityProceedings of the National Academy of Sciences, 1999
- L1-Specific Protection from Tumor Challenge Elicited by HPV16 Virus-like ParticlesVirology, 1998
- Monoclonal Antibodies to HPV-6 L1 Virus-like Particles Identify Conformational and Linear Neutralizing Epitopes on HPV-11 in Addition to Type-Specific Epitopes on HPV-6Virology, 1996
- Surface Conformational and Linear Epitopes on HPV-16 and HPV-18 L1 Virus-like Particles as Defined by Monoclonal AntibodiesVirology, 1996
- Systematic Analysis of Repeated Gene Delivery into Animal Lungs with a Recombinant Adenovirus VectorHuman Gene Therapy, 1996
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995
- Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodiesJournal of General Virology, 1994
- Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cellsEuropean Journal of Immunology, 1993